Skip to main content

Advertisement

ADVERTISEMENT

poster

Abstract: Introduction: Drug-induced movement disorders (DIMDs), including tardive dyskinesia (TD), are commonly associated with dopamine receptor-blocking medications. Benztropine is be...
01/19/2023
Introduction Experiential negative symptoms (ENS) are a major schizophrenia associated burden. Perceptions about the inability of people with schizophrenia to use technology are a barrier...
01/19/2023
Abstract: Introduction: The SEGUE study examines safety, tolerability, effectiveness, and treatment optimization in participants with narcolepsy transitioning from sodium oxybate (SXB) to...
01/19/2023
Abstract: Introduction: The TENOR study examines the transition from sodium oxybate (SXB) to lower-sodium oxybate (LXB; 92% less sodium than SXB) in a real-world setting. Methods: TENOR i...
01/19/2023
Bipolar disorder, previously known as manic depression, is a serious mental illness associated with extreme mood swings and manic/hypomanic episodes that interfere with an individual’s ab...
01/19/2023
Successful management of schizophrenia remains an elusive target for many clinicians. High rates of undertreatment and nonadherence result in poor outcomes among many patients, with signi...
01/19/2023
Excessive daytime sleepiness, or EDS substantially impacts individuals with psychiatric disorders, leading to heightened disability and mortality rates compared to the general population....
01/19/2023
Tardive dyskinesia, or TD, is a side effect of treatment with antipsychotic medications, resulting in repetitive and uncontrollable movements of the body and face. Affecting approximately...
01/19/2023
Abstract: Objective: This study evaluated the 2-year effectiveness of the first FDA-authorized prescription digital therapeutic (PDT) for adults with chronic insomnia that delivers eviden...
01/19/2023
Abstract: Introduction: Chronic insomnia (CI) often co-occurs with depression and anxiety. This ongoing study collected real-world data on changes in insomnia, depression, and anxiety sym...
01/19/2023

Advertisement